ÂÜÀòÂÒÂ×

Richard Berenson is an experienced executive in the life sciences and technology sectors, currently serving as President of Cardathea Inc., focused on developing advanced navigation systems for cardiac pacing leads. With a long-standing role as Managing Director at Venzyme Catalyst, LLC, and previous positions including CEO of HeartLander Surgical Inc., Berenson has a proven track record in leading innovative medical technology companies. Educational qualifications include an MBA with distinction from Harvard Business School, a JD from Harvard Law School, and an AB in Economics from Harvard University. Notable past roles include Chief Executive at Portal Insulin LLC, Chief Executive of Thermalin Inc., and Chief Financial Officer at SimulConsult, Inc., reflecting a broad expertise in executive leadership and medical advancements.